TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive NIH Scientists May Take Payment For Outside Teaching, Writing, Ethics Office Says In Final Rule September 11, 1992
TCL Archive FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules August 13, 1999
TCL Archive Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention October 14, 1994
TCL Archive Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS. February 15, 2002
